Return to homepagePandemic Pact

Prenatal exposure to maternal SARS-CoV-2 infection and early childhood development

  • Funded by Canadian Institutes of Health Research (CIHR)
  • Total publications:1 publications

Grant number: 202203PJT

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2022
    2027

  • Known Financial Commitments (USD)

    $689,188.5

  • Funder

    Canadian Institutes of Health Research (CIHR)

  • Principal Investigator

    N/A

  • Research Location

    Canada

  • Lead Research Institution

    University of Calgary

  • Research Priority Alignment

    N/A

  • Research Category

    Epidemiological studies

  • Research Subcategory

    Disease transmission dynamics

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Not applicable

  • Broad Policy Alignment

    Pending

  • Age Group

    Adults (18 and older)Children (1 year to 12 years)Infants (1 month to 1 year)Newborns (birth to 1 month)

  • Vulnerable Population

    Pregnant women

  • Occupations of Interest

    Unspecified

Abstract

Publicationslinked via Europe PMC

Last Updated:an hour ago

View all publications at Europe PMC

Psilocybin for treatment-resistant depression without psychedelic effects: study protocol for a 4-week, double-blind, proof-of-concept randomised controlled trial.